Expanding Therapeutic Possibilities Pursuing pMHC Targets Beyond Convention
- Antigen-guided TCE development
- Targeting haptenated peptides as a way of breaking HLA restriction
- Exploiting resistance mechanisms to cancer treatments that unlock new targets for immunotherapies
New Data